Physician profile
Arpan Patel
NPI 1528453966
$3,119.48
in general payments reported to CMS, 2019-2025
10 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.35 · 2021: $1,630 · 2022: $214 · 2023: $416 · 2024: $283 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,485.27 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Spr Therapeutics, INC | $262.57 | 2023-2025 | Sprint Pns System |
| Abbott Laboratories | $107.80 | 2022-2024 | Eterna |
| Nevro Corp. | $85.44 | 2023 | Senza |
| Biotronik Nro, INC. | $57.44 | 2024 | Prospera |
| Medtronic, INC. | $40.82 | 2021 | |
| Smith+Nephew, INC. | $23.34 | 2024 | Pico 7 |
| Globus Medical, INC. | $21.99 | 2025 | Senza |
| Si-Bone, INC. | $21.25 | 2024 | |
| Collegium Pharmaceutical, INC. | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.